Antiviral Activity of Prostaglandin A on Encephalomyocarditis Virus-infected Cells: A Unique Effect Unrelated to Interferon

References

1. Aguet M. 1980; High affinity binding of ¹²⁵I-labelled mouse interferon to a specific cell surface receptor. Nature, London 284:459–461
   [Google Scholar]
2. Baglioni C. 1979; Interferon-induced enzymatic activities and their role in the antiviral state. Cell 17:255–264
   [Google Scholar]
3. Baglioni C., Maroney P. A., West D. K. 1979; 2′5′oligo(A) polymerase activity and inhibition of viral RNA synthesis in interferon treated HeLa cells. Biochemistry 18:1765–1770
   [Google Scholar]
4. Bradford M. M. 1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
   [Google Scholar]
5. Chandrabose K. A., Cuatrecasas P., Pottathil R., Lang D. 1981; Interferon-resistant cell line lacks fatty acid cyclooxygenase. Science 212:329–331
   [Google Scholar]
6. Fitzpatrick F., Stringfellow D. 1980; Virus and interferon effects on cellular prostaglandin biosynthesis. Journal of Immunology 125:431–437
   [Google Scholar]
7. Fuse A., Mahmud I., Kuwata T. 1982; Mechanism of stimulation by human interferon of prostaglandin synthesis in human cell lines. Cancer Research 42:3209–3214
   [Google Scholar]
8. Jameson P., Dixon M., Grossberg S. E. 1977; A sensitive assay for many species of cells: encephalomyocarditis virus hemagglutination yield reduction. Proceedings of the Society for Experimental Biology and Medicine 155:173–178
   [Google Scholar]
9. Krause D., Silverman R. H., Jacobsen H., Leisy S. A., Dieffenbach C. W., Friedman R. M. 1985; Regulation of ppp(A2′p)_nA-dependent RNAse levels during interferon treatment and cell differentiation. European Journal of Biochemistry 146:611–618
   [Google Scholar]
10. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
11. Milhaud P. G., Faure T., Chaintreuil J., Cathala J. M., Lebleu B. 1983; Responses to interferon of LM cells growing continuously in the absence of serum and exogenous lipids. Journal of General Virology 64:485–489
    [Google Scholar]
12. Polet H., Levine L. 1975; Metabolism of prostaglandins E, A, and C in serum. Journal of Biological Chemistry 250:351–357
    [Google Scholar]
13. Pottathil R., Chandrabose K. A., Cuatrecasas P., Lang D. 1980; Establishment of the interferon-mediated antiviral state: role of fatty acid cyclooxygenase. Proceedings of the National Academy of Sciences, U. S. A 77:5437–5440
    [Google Scholar]
14. Ramabhadran T. V., Thach R. E. 1981; Translational elongation rate changes in encephalomyocarditis virus-infected and interferon-treated cells. Journal of Virology 39:573–583
    [Google Scholar]
15. Rueckert R. R., Pallansch M. A. 1981; Preparation of and characterization of encephalomyocarditis (EMC) virus. Methods in Enzymology 78:315–327
    [Google Scholar]
16. Santoro M. G., Benedetto A., Carruba G., Garaci E., Jaffe B. M. 1980; Prostaglandin A compounds as antiviral agents. Science 209:1032–1034
    [Google Scholar]
17. Santoro M. G., Carruba G., Garaci E., Jaffe B. M., Benedetto A. 1981; Prostaglandins of the A series inhibit Sendai virus replication in cultured cells. Journal of General Virology 53:75–83
    [Google Scholar]
18. Santoro M. G., Jaffe B. M., Garaci E., Esteban M. 1982a; Antiviral effect of prostaglandins of the A series: inhibition of vaccinia virus replication in cultured cells. Journal of General Virology 63:435–440
    [Google Scholar]
19. Santoro M. G., Jaffe B. M., Elia G., Benedetto A. 1982b; Prostaglandin A, induces the synthesis of a new protein in cultured AGMK cells. Biochemical and Biophysical Research Communications 107:1179–1184
    [Google Scholar]
20. Santoro M. G., Jaffe B. M., Esteban M. 1983a; Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein. Journal of General Virology 64:2797–2801
    [Google Scholar]
21. Santoro M. G., Jaffe B. M., Paez E., Esteban M. 1983b; The relationship between the antiviral action of interferon and prostaglandins in virus infected murine cells. Biochemical and Biophysical Research Communications 116:442–448
    [Google Scholar]
22. Silverman R. H., Watling D., Balkwill F. R., Trowsdale J., Kerr I. M. 1982; The ppp(A2′p)_n and protein kinase systems in wild type and interferon resistant Daudi cells. European Journal of Biochemistry 126:333–341
    [Google Scholar]
23. Stark G. R., Brown R. E., Kerr I. M. 1981; Assay of (2′-5′)-oligoadenylate synthetase levels in cells and tissues: a convenient poly(I) poly(C) paper-bound enzyme assay. Methods in Enzymology 79:194–199
    [Google Scholar]
24. Tovey M. G., Gresser I., Rochette-Egly C., Begon-Lours-Guymarho J., Bandu M. T., Maury C. 1982; Indomethacin and aspirin do not inhibit the antiviral or anti-proliferative actions of interferon. Journal of General Virology 63:505–508
    [Google Scholar]
25. Vengris V. E., Stollar B. D., Pitha P. M. 1975; Interferon externalization by producing cell before induction of antiviral state. Virology 65:410–417
    [Google Scholar]
26. Yaron M., Yaron D., Gurari-Rotman M., Revel M., Linder H., Zor U. 1977; Stimulation of prostaglandin E production in cultured human fibroblasts by poly(I) poly(C) and human interferon. Nature, London 261:457–459
    [Google Scholar]